Park Hye-Kyung, Lee Ji-Eun, Lim Jaehwa, Kang Byoung Heon
Department of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), 50 UNIST St,, Ulsan 689-798, South Korea.
Mol Cancer. 2014 Jun 12;13:148. doi: 10.1186/1476-4598-13-148.
Resistance to cell death in the presence of stressful stimuli is one of the hallmarks of cancer cells acquired during multistep tumorigenesis, and knowledge of the molecular mechanism of stress adaptation can be exploited to develop cancer-selective therapeutics. Mitochondria and the endoplasmic reticulum (ER) are physically interconnected organelles that can sense and exchange various stress signals. Although there have been many studies on stress propagation from the ER to mitochondria, reverse stress signals originating from mitochondria have not been well reported.
After inactivation of the proteins by pharmacologic and genetic methods, the signal pathways were analyzed by fluorescence microscopy, flow cytometry, MTT assay, and western blotting. A mouse xenograft model was used to examine synergistic anticancer activity and the action mechanism of drugs in vivo.
We show in this study that mitochondrial heat shock protein 90 (Hsp90) suppresses mitochondria-initiated calcium-mediated stress signals propagating into the ER in cancer cells. Mitochondrial Hsp90 inhibition triggers the calcium signal by opening the mitochondrial permeability transition pore and, in turn, the ER ryanodine receptor, via calcium-induced calcium release. Subsequent depletion of ER calcium activates unfolded protein responses in the ER lumen, thereby increasing the expression of a pro-apoptotic transcription factor, CEBP homologous protein (CHOP). Combined treatment with the ER stressor thapsigargin and the mitochondrial Hsp90 inhibitor gamitrinib augmented interorganelle stress signaling by elevating CHOP expression, and showed synergistic cytotoxic activity exclusively in cancer cells in vitro and in vivo.
Collectively, mitochondrial Hsp90s confer cell death resistance to cancer cells by suppressing the mitochondria-initiated calcium-mediated interorganelle stress response.
在应激刺激存在的情况下对细胞死亡产生抗性是癌细胞在多步骤肿瘤发生过程中获得的特征之一,了解应激适应的分子机制可用于开发癌症选择性疗法。线粒体和内质网(ER)是物理上相互连接的细胞器,能够感知并交换各种应激信号。尽管已有许多关于应激从内质网传播到线粒体的研究,但源自线粒体的反向应激信号尚未得到充分报道。
通过药理学和遗传学方法使蛋白质失活后,利用荧光显微镜、流式细胞术、MTT 法和蛋白质印迹法分析信号通路。使用小鼠异种移植模型在体内检测药物的协同抗癌活性及作用机制。
我们在本研究中表明,线粒体热休克蛋白 90(Hsp90)抑制癌细胞中线粒体引发的钙介导应激信号传播到内质网。线粒体 Hsp90 抑制通过打开线粒体通透性转换孔触发钙信号,进而通过钙诱导的钙释放激活内质网兰尼碱受体。内质网钙的随后耗竭激活内质网腔中的未折叠蛋白反应,从而增加促凋亡转录因子 CEB 同源蛋白(CHOP)的表达。内质网应激剂毒胡萝卜素与线粒体 Hsp90 抑制剂加米替尼联合治疗通过提高 CHOP 表达增强细胞器间应激信号,并在体外和体内仅在癌细胞中显示出协同细胞毒性活性。
总体而言,线粒体 Hsp90 通过抑制线粒体引发的钙介导的细胞器间应激反应赋予癌细胞对细胞死亡的抗性。